The National Security Commission on Emerging Biotechnology (NSCEB) announced on April 8, 2025, the availability of its final ...

The report warns, "Our window to act is closing. We need a two-track strategy: make America innovate faster, and slow China ...

The Federal Government has pledged comprehensive systems of policies, laws, and procedures designed to ensure the safe ...

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...

Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.

The US National Security Commission on Emerging Biotechnology has warned China is in a position to create practically ...

TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice today from the Nasdaq Stock Market ...

Find out how genome sequencing has emerged and what the future holds for one of biotech's most important tools.

For months, investors have feared that Health and Human Services Secretary Robert ... and key proponent of faster drug approvals—sent biotech stocks tumbling last month and stoked concerns ...

The biotech mergers and acquisitions market faces significant headwinds in the first half of 2025. These challenges include frozen capital ...

Uncertainties surrounding the U.S. pharmaceutical sector and the turbulent development in global stock markets have led to ...

Over the next four months, the Vaccine Integrity Project will hold information-gathering sessions with medical associations, ...